![](/img/cover-not-exists.png)
Irbesartan treatment does not influence plasma levels of the advanced glycation end products N (1-carboxymethyl)lysine and N (1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial
Engelen, L., Persson, F., Ferreira, I., Rossing, P., Hovind, P., Teerlink, T., Stehouwer, C. D., Parving, H.-H., Schalkwijk, C. G.Volume:
26
Language:
english
Journal:
Nephrology Dialysis Transplantation
DOI:
10.1093/ndt/gfr102
Date:
November, 2011
File:
PDF, 90 KB
english, 2011